Table:
begin	end	state
1	22	cytoplasmic
23	41	transmembrane
42	60	non-cytoplasmic
61	80	transmembrane
81	91	cytoplasmic
92	110	transmembrane
111	115	non-cytoplasmic
116	138	transmembrane
139	149	cytoplasmic
150	173	transmembrane
174	184	non-cytoplasmic
185	207	transmembrane
208	249	cytoplasmic
250	271	transmembrane
272	285	non-cytoplasmic
286	304	transmembrane
305	315	cytoplasmic
316	334	transmembrane
335	339	non-cytoplasmic
340	362	transmembrane
363	373	cytoplasmic
374	395	transmembrane
396	406	non-cytoplasmic
407	424	transmembrane
425	434	cytoplasmic

Input:
>Pf6N2E2_1312
MSTAHTANTAGTVAHDRTHATITWRLMPLLLVCYLFAHLDRINIGFAKMQMSADLQFSDT
VYGFGAGLFFIAYALFGVPSNMALDRVGPRRWIATLMVVWGALSSGMFLIDSAAGFYVLR
FLLGVAEAGFFPGILVFLNRWYPARRRAQVTALFAIAVPMAGVIGGPLSGGILEHFHDVG
GLRGWQWMFVIEGLPVILLGLVVLKCLPDDFETVKWLTPHAKQQLREQLSLEEQRKSITS
FSAILNNPQVWLLVAVYFAVMLAVNTLAFWMPTLIHGAGIGSDGKVGLLSAVPYLAGCFF
MIGCGRSSDRHRERRWHLCVPLLMAALGIAVTGLSPGNPILVLSGLIVAGMGASAALPMF
WQLPPAFLSNGTQAAGIALISSFGSIASFFAPYLIGWMRDTTQSASLALYALALLIALGG
LLVLRTHAAIVNPQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server